AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Bone Morphogenetic Proteins Industry (2020 to 2027) - Market Trends and Drivers - ResearchAndMarkets.com

December 29, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Dec 29, 2020--

The “Bone Morphogenetic Proteins - Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

The publisher brings years of research experience to the 9th edition of this report. The 188-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

ADVERTISEMENT

Global Bone Morphogenetic Proteins Market to Reach $589.5 Million by 2027

Amid the COVID-19 crisis, the global market for Bone Morphogenetic Proteins estimated at US$508 Million in the year 2020, is projected to reach a revised size of US$589.5 Million by 2027, growing at a CAGR of 2.1% over the period 2020-2027.

Recombinant human bone morphogenetic protein-2 (rhBMP-2), one of the segments analyzed in the report, is projected to record 2.3% CAGR and reach US$398.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Recombinant human bone morphogenetic protein-7 (rhBMP-7) segment is readjusted to a revised 1.8% CAGR for the next 7-year period.

The U. S. Market is Estimated at $149.5 Million, While China is Forecast to Grow at 1.7% CAGR

The Bone Morphogenetic Proteins market in the U. S. is estimated at US$149.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$103.2 Million by the year 2027 trailing a CAGR of 1.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2% and 1.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Competitors identified in this market include, among others:

  • Cellumed Co., Ltd.
  • Medtronic PLC
  • Stryker Corporation

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

ADVERTISEMENT

  • Global Competitor Market Shares
  • Bone Morphogenetic Proteins Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 53

For more information about this report visit https://www.researchandmarkets.com/r/f9ckve

View source version on businesswire.com:https://www.businesswire.com/news/home/20201229005358/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 12/29/2020 12:13 PM/DISC: 12/29/2020 12:13 PM

http://www.businesswire.com/news/home/20201229005358/en